Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
CGTX — Cognition Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2024 Earnings Call Summary

MAR 20, 2025
REVENUE
$0
EPS
-$0.17 +32.0%
FREE CASH FLOW
-$8.4M -22.4%

No summary has been written for this call yet.